Should the left lower paratracheal lymph node always be dissected in patients with left-sided lung cancer?
- 26 March 2020
- journal article
- letter
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 58 (2), 404
- https://doi.org/10.1093/ejcts/ezaa095
Abstract
No abstract availableKeywords
Funding Information
- Science and Technology Bureau of Sichuan (2017RZ0045)
This publication has 4 references indexed in Scilit:
- Impact of L4 lymph node dissection on long-term survival in left-side operable non-small-cell lung cancer: a propensity score matching studyEuropean Journal of Cardio-Thoracic Surgery, 2020
- Lobe-Specific Lymph Node Dissection for Clinical Early-Stage (cIA) Peripheral Non-small Cell Lung Cancer Patients: What and How?Annals of Surgical Oncology, 2019
- Survival Benefit of Left Lower Paratracheal (4L) Lymph Node Dissection for Patients with Left-Sided Non-small Cell Lung Cancer: Once Neglected But of Great ImportanceAnnals of Surgical Oncology, 2019
- Clinical Significance of 4L Lymph Node Dissection in Left Lung CancerJournal of Clinical Oncology, 2018